Our research into prostate cancer
120 years of life-saving discoveries
Our scientists have been at the forefront of cancer research since 1902.
Thanks to you, we’ve come so far. And we will go much further.
Together, we will beat cancer.
Our research is saving lives
Prostate cancer is the most common cancer in men in the UK, but more than 8 in 10 (84%) of patients now survive their disease for 10 years or more. We are at the heart of this progress – playing pivotal roles in the development of treatments like abiraterone and intensity modulated radiotherapy.
Current research
From studying the biology of prostate cancer cells in the lab to leading clinical trials testing cutting-edge treatments, our researchers are working hard to ensure more men survive prostate cancer.
Past research
Thanks to research, we've helped change the outlook for men with prostate cancer.
Patients' stories
Meet people like Alfred who have experienced first-hand how our research is making a difference. The life-saving research we do wouldn’t be possible without your support.
Further information
Our strategy to beat cancer sooner
Over the last 40 years, cancer survival in the UK has doubled. In the 1970s just 1 in 4 people survived their disease for 10 years or more. Today 2 in 4 survive.
We want to accelerate progress and see 3 in 4 patients surviving the disease by 2034.